Muro's prednisolone syrup
Executive Summary
Firm is requesting permission to submit an ANDA for a 5 mg/5 ml prednisolone syrup and asking FDA to approve a waiver from in vivo bioavailability studies. Muro says it conducted in vivo bioavailability studies for a 15 mg/5 ml prednisolone syrup and a 5 mg/5 ml prednisone syrup, which contain identical excipients at approximate concentrations as the proposed product.